CureLauncher launches to play clinical trial matchmaker; Medidata exec endows data science fellowship at NYU;

@RyanMFierce: Monday at ASCO marked by bad news from $SNY, $LLY after feel-good weekend for $MRK, $BMY. | Follow @RyanMFierce

> Michigan-based CureLauncher has rolled out a service that matches patients with clinical trials that meet their personalized goals. Release

> GNS Healthcare has added Dr. Howard Weiner, Dr. Pia Sormani and Dr. Philip De Jager to its Multiple Sclerosis Scientific Advisory Board after announcing plans to improve computer-based models of the autoimmune disease. Announcement

> Medidata Solutions ($MDSO) President Glen de Vries (a 2012 Biotech Techie) has endowed a student fellowship at New York University's Center for Data Science with a $275,000 gift. Release

> The Broad Institute has debuted open-source software for genome assembly and variant calling. News

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.